During the past decade, Istituti Fisioterapici Ospitalieri - Roma conducted 46 clinical trials. In the 10-year time frame, 46 clinical trials started and 8 clinical trials were completed, i.e. on average, 17.4% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 4 clinical trials were completed. i.e. 18.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Istituti Fisioterapici Ospitalieri - Roma" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 14 trials, followed by "Italian Sarcoma Group" with 11 trials sponsored, "Fondazione Italiana Linfomi ONLUS" with 5 trials sponsored, "Consorzio Oncotech" with 4 trials sponsored and "National Cancer Institute, Naples" with 4 trials sponsored. Other sponsors include 51 different institutions and companies that sponsored additional 48 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Istituti Fisioterapici Ospitalieri - Roma" #1 collaborator was "Merck Sharp & Dohme LLC" with 4 trials as a collaborator, "Clinical Research Technology S.r.l." with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Intergroupe Francophone de Cancerologie Thoracique" with 2 trials as a collaborator and "Ministry of Health, Italy" with 2 trials as a collaborator. Other collaborators include 48 different institutions and companies that were collaborators in the rest 55 trials.

According to Clinical.Site data, the most researched conditions in "Istituti Fisioterapici Ospitalieri - Roma" are "Breast Cancer" (6 trials), "Head and Neck Cancer" (4 trials), "Lung Cancer" (4 trials), "Metastatic Breast Cancer" (4 trials) and "Non-Small Cell Lung Cancer" (4 trials). Many other conditions were trialed in "Istituti Fisioterapici Ospitalieri - Roma" in a lesser frequency.

Most popular intervention types in "Istituti Fisioterapici Ospitalieri - Roma" are "Drug" (80 trials), "Other" (17 trials), "Radiation" (7 trials), "Procedure" (4 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Rituximab" (5 trials), "cisplatin" (5 trials), "Pembrolizumab" (4 trials) and "fluorouracil" (4 trials). Other intervention names were less common.

The vast majority of trials in "Istituti Fisioterapici Ospitalieri - Roma" are 77 trials for "All" genders, 16 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Istituti Fisioterapici Ospitalieri - Roma". undefined are not yet recruiting, 21 are recruiting, 23 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in Istituti Fisioterapici Ospitalieri - Roma, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Istituti Fisioterapici Ospitalieri - Roma, 3 "Phase 1" clinical trials were conducted, 36 "Phase 2" clinical trials and 40 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".

Istituti Fisioterapici Ospitalieri - Roma has several departments that took part in Clinical trials: "Istituto Regina Elena; Oncologia Medica A" - 23 trials, "S.C. di Ematologia e Trapianti - I.F.O. Istituto Nazionale Tumori Regina Elena" - 20 trials, "Istituto Regina Elena, Divisione di Oncologia Medica" - 4 trials, "Oncologia Medica 2 - Istituto Nazionale Tumori "Regina Elena"" - 2 trials, "Istituto Dermatologico San Gallicano" - 2 trials